Satcure Bioscience LLP

• Tigecycline Injection IP 500 mg is a broad-spectrum glycylcycline antibiotic designed to combat multidrug-resistant (MDR) bacterial infections. It is used in the treatment of complicated intra-abdominal infections, skin and soft tissue infections, and community-acquired bacterial pneumonia.

   

  This formulation is intended for hospital and critical care settings, and is a preferred choice by healthcare professionals globally for resistant infections.

• Broad-spectrum coverage, including MRSA, VRE, and resistant Gram-negative strains

• Lyophilized powder formulation for extended shelf life

• GMP certified manufacturing standards

• Ideal for global export (compliance-ready for international markets)

• Customizable bulk packaging available on demand

• Complicated Intra-Abdominal Infections

• Complicated Skin and Soft Tissue Infections (SSTIs)

• Community-Acquired Pneumonia (CAP)

• Alternative treatment in cases of antibiotic resistance

SATCURE BIOSCIENCE LLP specializes in the export of critical care injectables including Tigecycline. We serve clients across Latin America, Africa, Middle East, and Southeast Asia. Our logistics team ensures temperature-controlled dispatch and timely deliveries, globally.

#TigecyclineInjection #PharmaceuticalExporters #AntibioticInjection #CriticalCareInjectables #PharmaManufacturerIndia #SatcureBioscience #BroadSpectrumAntibiotics

• Tranexit is a sterile, ready-to-use Tranexamic Acid Injection IP designed for rapid hemostatic control in surgical and traumatic bleeding scenarios. Engineered under stringent quality protocols, our Tranexamic Acid Injection offers a robust antifibrinolytic solution, ensuring optimal patient outcomes and operational efficiencies for healthcare providers.

• High-Purity Formulation: Contains Tranexamic Acid 100 mg/mL in an isotonic aqueous vehicle, free from pyrogens and particulate matter.

• Rapid Hemostasis: Inhibits plasminogen activation, minimizing perioperative and postpartum hemorrhage.

• WHO‑GMP Compliance: Manufactured in a state‑of‑the‑art, WHO‑GMP certified facility, ensuring consistent batch‑to‑batch quality.

• Advanced Sterility Assurance: Terminally sterilized and double‑sealed for extended shelf life and protection against microbial contamination.

• Patient‑Centric Packaging: Available in 10 mL and 20 mL Type I glass vials with tamper‑evident caps, facilitating safe administration.

At Satcure Bioscience, we leverage cutting‑edge process controls and rigorous in‑process testing to deliver Tranexit with unparalleled purity and potency. Our QC protocols encompass:

• Raw Material Traceability: Sourced from ISO‑certified vendors with full chain‑of‑custody documentation.

• In‑Line Monitoring: Real‑time analytics for pH, osmolality, and endotoxin levels.

• Stability Studies: Long‑term and accelerated stability programs in alignment with ICH guidelines.

• Vangril 500 is a high-quality Vancomycin HCL Injection 500mg, used to treat serious bacterial infections caused by Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). It is a glycopeptide antibiotic that works by inhibiting bacterial cell wall synthesis, offering powerful protection against life-threatening infections when other antibiotics fail.

   

  Formulated in a GMP-certified facility, our Vancomycin 500mg injection ensures high efficacy, purity, and patient safety.

• Broad‑Spectrum Gram‑Positive Coverage
  Proven efficacy against MRSA and other resistant strains.

• Pharmaceutical‑Grade Purity
  Manufactured under stringent WHO‑GMP guidelines, ensuring batch‑to‑batch consistency.

• Optimized Stability Profile
  Superior formulation minimizes risk of precipitation, maintaining potency during infusion.

• Cost‑Effective Supply Chain
  Competitive pricing model for bulk and institutional procurement.

• Severe MRSA infections

• Endocarditis and bone/joint infections

• Complicated skin and soft tissue infections

• Pneumonia in hospitalized patients

• Empirical therapy in febrile neutropenia

1. Dedicated Supply Assurance – Reliable “Vancomycin HCL IP 500 supplier” commitment for hospitals and clinics.

2. Regulatory Expertise – Seamless dossier support for state and central drug authorities.

3. Customized Pricing Solutions – Flexible “buy Vancomycin Injection online” models for distributors.

4. Technical Support – 24×7 pharmacovigilance and clinical liaison assistance.

For bulk pricing, technical dossiers, or to place an order for Vangril 500 you can message on INDIAMART. 

• SUNCOLIS is a high-quality Colistimethate Sodium for Injection IP 1 Million IU, manufactured under stringent quality standards. It is indicated for the treatment of multidrug-resistant Gram-negative bacterial infections. SUNCOLIS is widely recommended in critical care and ICU settings for its proven efficacy and patient tolerance

• High‑Potency Formulation

  • Each vial contains 1 Million IU of Colistimethate Sodium IP, providing a robust antimicrobial index against Pseudomonas aeruginosa, Acinetobacter baumannii, and other resistant strains.

• Optimized Pharmacokinetics

  • Rapid conversion to active colistin in vivo ensures sustained bactericidal activity, supporting dose scheduling flexibility.

Safety & Compliance

• Manufactured in a WHO‑GMP‑certified facility, with full adherence to IP monograph specifications.

• Supplied with batch‑specific certificate of analysis and endotoxin testing, ensuring sterility and safety.

SUNCOLIS is indicated for:

1. Treatment of severe hospital‑acquired and ventilator‑associated pneumonia caused by susceptible gram‑negative bacilli.

2. Management of complicated urinary tract infections when multidrug resistance precludes alternative therapy.

3. Salvage therapy for bloodstream infections and intra‑abdominal infections due to resistant pathogens.

By integrating SUNCOLIS into antimicrobial stewardship protocols, institutions can optimize outcomes in critically ill patients while mitigating resistance development.

• Strategic Supply Chain: Reliable inventory management ensures uninterrupted availability.

• Dedicated Technical Support: Access to our 24/7 medical liaison team for on‑site training and protocol development.

• Competitive Pricing: Flexible tender rates and volume discounts tailored to institutional budgets.

• Regulatory Assurance: Fully compliant with Indian Pharmacopoeia (IP) and national drug control regulations.

• Teicobest (Teicoplanin Injection IP 400mg) is a high-quality, broad-spectrum antibiotic used for the treatment of serious bacterial infections, especially those caused by Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). Manufactured under strict GMP standards, Teicobest is trusted by healthcare professionals for its proven efficacy, safety profile, and consistent results.

   

  This injectable antibiotic is used in hospitals and clinics for treating skin infections, bone and joint infections, respiratory tract infections, and septicemia. It is a reliable choice in critical care and infectious disease management.

Key Features & Benefits

• Clinical‑Grade Purity: Each vial of Teicoplanin Injection IP 400 mg undergoes rigorous in‑house quality control to ensure endotoxin levels, sterility, and assay purity far exceed regulatory benchmarks.

• Potent Antibacterial Spectrum: Effective against methicillin‑resistant Staphylococcus aureus (MRSA), Enterococcus spp., and other multidrug‑resistant Gram‑positive pathogens.

• Optimized Pharmacokinetics: With a long half‑life and favorable tissue penetration, Teicobest supports once‑daily dosing, reducing nursing burden and improving patient compliance.

• Stable Formulation: Lyophilized powder in single‑dose, tamper‑evident vials ensures product integrity during storage and transport.

Packaging & Supply Options

• Packaging: 10 vials per carton (400 mg/vial), with clear labeling and batch traceability.

• MOQ & Lead Time: Minimum order quantity of 100 vials; typical dispatch within 7–10 business days from receipt of PO.

• Logistics: Temperature‑controlled transport and end‑to‑end cold‑chain monitoring available.

• Rapson Rabeprazole Injection IP 20 MG is a sterile, preservative‑free formulation designed to deliver rapid and consistent acid‑suppression therapy. Each vial contains 20 mg of Rabeprazole sodium, manufactured under stringent WHO‑GMP and ISO standards, ensuring high potency, exceptional stability, and patient safety. Ideal for hospital pharmacies, critical care units, and gastroenterology practices, Rapson Injection addresses acute gastric acid‑related disorders with precision and reliability.

• Rapid Onset of Action: Provides fast and sustained reduction of gastric acid secretion, supporting management of peptic ulcers and gastroesophageal reflux disease (GERD).

• High Bioavailability: Ensures predictable pharmacokinetics for consistent therapeutic outcomes in acute care settings.

• Sterile, Pyrogen‑Free: Manufactured in state‑of‑the‑art cleanrooms to minimize risk of contamination.

• Easy Reconstitution: Clear solution with minimal particulate matter; ready for intravenous administration within minutes.

• Extended Shelf Life: Robust packaging maintains potency up to the labelled expiry date under recommended storage conditions.

• Acute Gastric Ulcers: Accelerates healing by suppressing acid secretion.

• Severe GERD Episodes: Reduces reflux symptoms and esophagitis in hospitalized patients.

• Zollinger–Ellison Syndrome: Provides effective long‑term control of hypersecretory states.

• Pre‑operative Acid Reduction: Ensures gastric pH optimization prior to anesthesia.

1. Superior Manufacturing Compliance: Produced in WHO‑GMP and ISO 9001:2015 certified facilities.

2. Robust Quality Assurance: Each batch undergoes HPLC potency assay, sterility, and endotoxin testing.

3. Competitive Supply Chain: Consistent availability with flexible MOQs and prompt dispatch.

4. Dedicated Technical Support: On‑time documentation (COA, MSDS, and stability data) to streamline procurement.

We are actively looking for channel partners, distributors, and institutional buyers. Attractive pricing and logistic support available for bulk orders across India and international markets.

📦 Minimum Order Quantity: As per buyer requirement
🌍 Supply Location: PAN India & Export Available
📞 For Enquiries: Contact us via IndiaMART or Call/Email for best rates

• Risucrose is a high-quality Iron Sucrose Injection USP, specially formulated to treat iron deficiency anemia in patients with chronic kidney disease (CKD). Manufactured under strict GMP standards, Risucrose offers fast absorption, high bioavailability, and excellent patient tolerance, making it a reliable choice for hospitals, clinics, and pharma distributors.

• High Bioavailability: Delivers elemental iron efficiently with >95 % utilization, minimizing free‐iron toxicity.

• Controlled Release Profile: Proprietary sucrose‐complex matrix ensures gradual iron delivery, reducing risk of hypersensitivity.

• pH-Buffered Formulation: Maintains physiologic pH for enhanced patient comfort and compatibility with infusion systems.

• Regulatory Compliance: Manufactured in WHO‑GMP certified facilities; meets all USP monograph requirements.

• Versatile Dosing: Available in single‑dose 20 mL vials (containing 100 mg elemental iron) for customizable infusion regimens.

• Treatment of chronic kidney disease (CKD)–related anemia

• Management of chemotherapy‐induced iron deficiency

• Supportive therapy in perioperative and postpartum anemia

• Correction of iron deficiency in malabsorption syndromes

• Supply Chain Excellence: End‑to‑end cold‑chain logistics for zero‑compromise product integrity.

• Competitive MOQ & Pricing: Flexible minimum order quantities tailored to distributors, hospitals, and clinics.

• Regulatory Support: Complete dossier (DMF, CEP, COA) for seamless import/export and market registration.

• After‑Sales Service: 24/7 technical support and pharmacovigilance assistance.

RIAMOL is a high-quality Paracetamol Infusion IP 0.1% w/v, manufactured to ensure fast and effective relief from moderate pain and fever in hospital and clinical settings. Specially formulated for intravenous use, this infusion is ideal for patients who are unable to take oral medications.

With its rapid onset of action, RIAMOL provides quick temperature reduction and pain control, particularly in post-operative care, ICU patients, and in emergency medical cases. It is a widely used antipyretic and analgesic solution across nursing homes, hospitals, and medical institutions.

• Sterile Infusion Solution formulated under stringent cGMP guidelines, ensuring endotoxin‑free delivery and optimal patient safety.

• High‑Purity Paracetamol (0.1% W/V) delivering precise analgesic and antipyretic effects, ideal for controlled intravenous administration in clinical settings.

• Pyrogen‑Tested & Non‑Hemolytic for safe use in pediatric, adult, and geriatric populations requiring rapid fever control and pain management.

• Ready‑to‑Use Infusion Bag compatible with all standard IV infusion sets, reducing preparation time and minimizing handling errors.

• Comprehensive Quality Assurance including in‑process monitoring, validated sterilization cycles, and rigorous batch release testing.

• Management of moderate to severe pain when oral therapy is unsuitable

• IV antipyresis in febrile patients unresponsive to oral antipyretics

• Adjunctive analgesia in postoperative pain protocols

• Fever control in oncology and critical‑care environments

• Presentation: 100 mL IV infusion bag (each containing 100 mg Paracetamol)

• Shelf Life: 24 months from date of manufacture

• Storage Conditions: Store at 2 °C – 8 °C; protect from light; do not freeze.

MEZDOC 1GM is a high-quality Ceftazidime Injection IP 1gm, manufactured with strict adherence to industry standards to ensure safety, sterility, and efficacy. It belongs to the third-generation cephalosporin antibiotics, widely used in hospitals and clinics for the treatment of severe bacterial infections.

This injectable solution is highly effective against gram-negative bacterial infections, including pneumonia, urinary tract infections, intra-abdominal infections, meningitis, and skin and soft tissue infections.

Clinical Benefits & Applications

• Broad‑Spectrum Coverage: Effective against Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, and other resistant strains.

• Rapid Onset: Achieves therapeutic plasma levels within minutes of intravenous administration.

• Tissue Penetration: Demonstrates optimal distribution in respiratory tract, urinary tract, skin and soft tissue, intra‑abdominal, and bone/joint infections.

• Reduced Resistance Potential: Third‑generation cephalosporin scaffold engineered to minimize β‑lactamase degradation.

Quality Assurance & Compliance

• Manufactured in an ISO 9001 and WHO‑GMP certified facility

• Stringent in‑process and final QC testing: assay, sterility, endotoxin, particulate matter

• Compliant with Pharmacopoeial standards (IP, BP, USP)

• Batch traceability and rigorous stability studies

Why Partner with Us?

• Dedicated Supply Chain: On‑time delivery and customized order fulfillment

• Regulatory Support: Comprehensive dossiers for global registrations

• Technical Collaboration: Expert pharmacovigilance and clinical support teams

• Competitive Pricing: Economies of scale without compromising on quality

If you're a hospital buyer, pharma distributor, clinic, or procurement manager, reach out to us for competitive bulk pricing and fast delivery options.

• MEROGRIL L is a high-quality Meropenem Injection IP 1GM, specially formulated to treat a wide range of serious bacterial infections. It belongs to the carbapenem class of antibiotics, known for its broad-spectrum action against both Gram-positive and Gram-negative organisms.

   

  Our Meropenem injection is manufactured under WHO-GMP certified facilities, ensuring international quality and regulatory compliance. It is widely used in hospitals and critical care settings for the treatment of infections such as pneumonia, skin and soft tissue infections, intra-abdominal infections, urinary tract infections, and bacterial meningitis.

Key Features & Benefits

• Active Ingredient: Meropenem IP 1 Gm per vial

• Sterility & Purity: Lyophilized powder in a preservative‑free, single‑use vial

• Broad‑Spectrum Efficacy: Covers ESBL‑producing Enterobacteriaceae and multi‑drug resistant Pseudomonas aeruginosa

• Rapid Bactericidal Action: Time‑dependent killing for aggressive infection management

• High Tissue Penetration: Optimal cerebrospinal and pancreatic tissue distribution

• Flexible Dosing: Can be administered via IV bolus or infusion, tailored to patient needs

Quality Assurance

• WHO‑GMP certified facility

• ISO 9001:2015 and ISO 13485:2016 compliant

• End‑product sterility testing per IP standards

• Batch release with full analytical report

Therapeutic Indications

• Complicated intra‑abdominal infections

• Bacterial meningitis (in adults and pediatric populations)

• Skin and soft tissue infections

• Febrile neutropenia

• Lower respiratory tract infections

Why Choose MEROGRIL L?

1. Guaranteed Compliance: Meets all IP monograph standards.

2. Competitive Pricing: Cost‑effective margins for distributors.

3. Robust Supply Chain: Consistent stock availability with on‑time delivery.

4. Dedicated Support: 24×7 technical and regulatory assistance.

• Composition: Contains Meropenem, a broad-spectrum carbapenem antibiotic used in injectable form.

• Indications: Used to treat severe bacterial infections such as pneumonia, urinary tract infections, meningitis, skin infections, intra-abdominal infections, and sepsis.

• Mechanism of Action: Works by inhibiting bacterial cell wall synthesis, leading to bacterial death; resistant to many beta-lactamase enzymes.

• Dosage & Administration: Administered intravenously, typically 500 mg to 2 g every 8 hours, with dose adjustments for renal impairment.

Satcure Bioscience LLP is pleased to present Levetiracetam Injection USP 100 mg, a dependable antiepileptic medication designed for managing diverse seizure disorders. This injection format proves particularly valuable in hospital environments and intensive care units, delivering swift therapeutic effects for patients who cannot receive oral treatment.

🧪 Active Ingredient: Levetiracetam 100 mg per vial

✅ Format: Injectable formulation

📦 Vial Options: 5 ml / 10 ml containers (adaptable to requirements)

🚚 Shipping Duration: 7–10 business days across India

🌍 International Standard: Ready for global distribution

💊 Application: Treatment of partial seizures and epileptic conditions

✔ WHO-GMP Certified Production Facility

✔ Cost-Effective Rates for Volume Orders

✔ Tailored Packaging & Branding Solutions

✔ Quick & Secure Transportation

✔ Established Supplier to 20+ Nations

This Levetiracetam injection finds extensive application across medical facilities including hospitals, emergency departments, neurological units, and intensive care centers. The medication is prescribed for both adult and pediatric cases under appropriate medical guidance.

For additional information, volume pricing, or international shipping quotes, please reach out to Satcure Bioscience LLP – your reliable source for premium pharmaceutical products.

• LETINE (Levocarnitine Injection USP) is a high-purity, pharmaceutical-grade L-carnitine supplement used in hospitals and clinics to treat carnitine deficiency in patients with kidney disease or undergoing dialysis. Manufactured under strict WHO-GMP standards, LETINE ensures reliable potency, sterility, and clinical safety.

  Levocarnitine plays a vital role in energy production by transporting long-chain fatty acids into mitochondria. It is especially useful in conditions like:

   

  • Chronic kidney failure

  • Cardiac and muscle disorders

  • Dialysis-related deficiency

  • Fatigue and metabolic support

• �� Why Choose LETINE?

  ✔️ Manufactured in WHO-GMP certified facility
  ✔️ Export-quality formulation for global markets
  ✔️ Competitive wholesale price for bulk buyers
  ✔️ Safe, sterile, and stable shelf-life
  ✔️ Trusted by hospitals, distributors & medical exporters

• Satcure Bioscience LLP is a trusted pharmaceutical exporter from India, offering Levocarnitine Injection USP to clients in:

  • Latin America

  • Middle East

  • African countries

  • Southeast Asia

  • CIS & European regions

  We provide end-to-end export documentation, COA, MSDS, and custom packaging on request.

  �� MOQ & Delivery:

  ✅ Minimum Order Quantity: 1000 units
  ✅ Fast dispatch | OEM/private labelling available
  ✅ Custom branding for contract manufacturing clients

Whether you're a hospital buyer, distributor, or pharma sourcing agent, reach out to us for competitive pricing, COA samples, and free quotations.

• Asco Saga is a premium-quality Ascorbic Acid Injection IP, developed for intravenous administration under clinical supervision. Enriched with Vitamin C (ascorbic acid), this injectable formulation is intended to support treatment in cases of vitamin C deficiency, post-surgical recovery, and immunity-boosting protocols.

   

  Manufactured under stringent GMP-WHO compliant conditions, Asco Saga delivers high bioavailability, purity, and fast absorption, ensuring maximum therapeutic benefits in medical settings.

1. Scalable Supply Chain: Robust inventory and flexible MOQ to accommodate bulk orders and custom‑packaging requirements.

2. Regulatory Compliance: Comprehensive dossier support, including COA, MSDS, and stability data.

3. Ongoing Technical Support: Dedicated pharma‑liaison team for seamless order processing, shipping logistics, and regulatory consultation.

4. Competitive Lead Times: Streamlined manufacturing slots ensure prompt dispatch within 4–6 weeks of PO confirmation.

• Cefoking 3gm is a high-quality sterile injection composed of Cefoperazone (2g) and Sulbactam (1g). This third-generation cephalosporin antibiotic is highly effective against a wide range of gram-positive and gram-negative bacterial infections. It works by inhibiting bacterial cell wall synthesis, while Sulbactam acts as a beta-lactamase inhibitor, enhancing the efficacy of Cefoperazone.

  This powerful combination is widely used in hospitals and clinics for the treatment of severe bacterial infections, including:

  • Respiratory tract infections

  • Urinary tract infections

  • Intra-abdominal infections

  • Skin and soft tissue infections

  • Septicemia

  • Bone and joint infections

  • Gynecological infections

  Key Features:

  • Brand Name: Cefoking 3gm

  • Composition: Cefoperazone Sodium 2gm + Sulbactam Sodium 1gm

  • Packing: Glass vial with sterile water for injection

  • Strength: 3 grams total content

  • Route of Administration: IV/IM (Intravenous/Intramuscular)

  • Storage: Store in a cool, dry place. Protect from light.

  Why Choose Cefoking 3gm?

   

  • Manufactured under WHO-GMP certified facilities

  • Accurate dosage formulation for consistent results

  • Broad-spectrum antibacterial activity

  • Reliable efficacy and excellent patient tolerance

  • Bulk quantity available for hospitals, distributors, and pharmacies

• Product Availability:

  We offer bulk supply at competitive prices with full documentation support including COA, MSDS, and stability data. Export inquiries are welcome with customized packaging options available upon request.

• Fibroclot 5 (Heparin Sodium Injection IP) is a high-quality anticoagulant injection used primarily for the prevention and treatment of blood clots in veins, arteries, or lungs. Manufactured under strict GMP standards, Fibroclot 5 is a trusted choice by healthcare providers for managing and preventing conditions such as deep vein thrombosis (DVT), pulmonary embolism, and myocardial infarction.

   

  This injectable solution is known for its fast-acting blood-thinning properties, effectively reducing the risk of complications associated with clot formation during or after surgeries, dialysis, and various critical care procedures.

• High‑Purity Heparin Sodium: Manufactured to IP standards, Fibroclot 5 provides predictable anticoagulant activity, minimizing batch‑to‑batch variability.

• Low Particulate Load: Advanced filtration processes reduce particulate content for greater patient safety during vascular infusion.

• Ready‑to‑Use Presentation: Supplied in pre‑filled, tamper‑evident ampoules to streamline dosing and reduce preparation errors.

• Broad‑Spectrum Anticoagulant: Effective in hemodialysis, cardiopulmonary bypass, and critical care applications, supporting diverse clinical protocols.

• Stability & Shelf‑Life: Robust formulation offers extended shelf stability at room temperature, optimizing inventory management.

• Hemodialysis Anticoagulation

• Cardiopulmonary Bypass Support

• Central Venous Catheter Lock

• Thrombus Prevention in Vascular Devices

• Intensive Care Unit Anticoagulant Regimens

1. Regulatory Compliance: Manufactured in an ISO‑certified facility with end‑to‑end traceability.

2. Quality Assurance: Rigorously tested for endotoxins, sterility, and anticoagulant potency.

3. Patient Safety: Designed with low endotoxin levels and minimal particulate risk.

4. Operational Efficiency: Pre‑dosed ampoules reduce nurse handling time and minimize medication errors.

• Fibropatin 0.4 is a high-quality Enoxaparin Sodium Injection IP, widely used as an anticoagulant to prevent and treat blood clots in the body. Manufactured under stringent quality controls, this low molecular weight heparin (LMWH) injection is highly effective in the prophylaxis and treatment of deep vein thrombosis (DVT), pulmonary embolism (PE), and other clot-related conditions, especially in post-surgery or hospitalized patients.

   

  This product is offered in a pre-filled syringe of 40mg/0.4ml and ensures consistent dosing with minimal risk of contamination.

Key Highlights

• High‑Purity Enoxaparin Injection: Manufactured under stringent cGMP protocols to ensure consistent anti‑thrombotic efficacy.

• Precise 0.4 mL Dosage: Delivers 40 mg of Enoxaparin Sodium per pre‑filled syringe for accurate, ready‑to‑use anticoagulant therapy.

• Sterile, Single‑Use Format: Minimizes contamination risk and supports safe inpatient and outpatient administration.

• Long‑Shelf Stability: Robust formulation ensures up to 24 months of stability at 2–8 °C, reducing supply‑chain waste.

Core Benefits

1. Optimized Patient Outcomes: Proven to reduce incidence of post‑operative DVT and PE with a low risk of heparin‑induced thrombocytopenia.

2. Operational Efficiency: Pre‑filled syringes accelerate point‑of‑care administration, streamlining workflow in busy hospital and clinic settings.

3. Regulatory Compliance: Fully compliant with IP monographs and international pharmacopeial standards.

4. Robust Supply Assurance: Dedicated production lines and validated cold‑chain logistics for uninterrupted stock availability.

Composition: Glutasun contains 600 mg of Glutathione, a powerful antioxidant naturally found in the body. It plays a crucial role in detoxification, immune support, and cellular protection.

Indication: Commonly used for skin brightening, anti-aging, and detoxification therapy. It may also support liver health and be used as an adjunct in conditions associated with oxidative stress.

Administration: Administered via intravenous (IV) injection or infusion, typically under medical supervision. The frequency and duration depend on the treatment goal (e.g., cosmetic vs therapeutic use).

Precautions & Side Effects: Generally well-tolerated, but may cause allergic reactions, abdominal cramps, or rash in rare cases. Should be used with caution in patients with asthma or hypersensitivity to sulfur-containing compounds.

• Tazoria 1.125 is a broad-spectrum antibiotic injection that combines Piperacillin and Tazobactam for enhanced antibacterial efficacy. It is used in hospitals for the treatment of moderate to severe bacterial infections, including lower respiratory tract, urinary tract, intra-abdominal, skin, and soft tissue infections. Known for its fast action and clinical reliability, Tazoria 1.125 ensures effective infection control. It is administered intravenously under medical supervision and is widely trusted across healthcare institutions. Manufactured under stringent quality standards, it is ideal for bulk hospital supply and pharmacy procurement. Satcure Bioscience ensures affordability and high product integrity.

• Optimized Antimicrobial Spectrum: Targets Gram‑negative, Gram‑positive, and anaerobic pathogens through dual‑mechanism action, reducing resistance risk.

• Pharma‑Grade Compliance: Manufactured under rigorous GMP and IP standards, with full documentation for traceability and regulatory audits.

• Sterile Presentation: Single‑dose vials in preservative‑free formulation ensure patient safety and reduce contamination potential.

• Cost‑Effective Bulk Supply: Competitive pricing tiers for distributors and institutional buyers seeking low‑cost Piperacillin Tazobactam Injection suppliers in India.

• Indications: Complicated intra‑abdominal infections, skin and soft tissue infections, nosocomial pneumonia, and febrile neutropenia.

• Dosage Guidelines: Administer 3.375 GM to 4.5 GM every 6 – 8 hours IV infusion, adjusted per renal function and infection severity.

• Quality Certification: ISO 9001:2015 and WHO‑GMP certified facilities; each batch undergoes sterility, endotoxin, and potency assays.

• Packaging: Available in 1.125 GM glass vials, packed in protective high‑density cartons with desiccant inserts. Custom labeling and secondary packaging solutions upon request.

• Dedicated Supply Chain: Real‑time inventory management, seamless logistics, and reliable delivery across Indian metros and remote regions.

• Technical Support: Access to pharmacovigilance data, clinical liaison services, and bespoke training modules for your sales team.

• Flexible MOQs: Scale orders with minimal commitment, optimizing your working capital and reducing inventory carrying costs.

Fenac AQ – Diclofenac Sodium Injection IP is a fast-acting, non-steroidal anti-inflammatory drug (NSAID) indicated for the effective relief of moderate to severe pain and inflammation. Manufactured with strict quality standards, Fenac AQ is formulated using Diclofenac Sodium, a trusted active ingredient widely used in pain management protocols.
This injectable solution provides quick relief from conditions such as post-operative pain, musculoskeletal disorders, rheumatoid arthritis, gout attacks, and orthopedic injuries. Fenac AQ is ideal for hospital setups, clinical usage, and emergency care settings.Composition: Contains Diclofenac Sodium in an aqueous solution, usually available as 75 mg per ampoule for injection.

Indications: Used for the management of moderate to severe pain and inflammation, including postoperative pain, musculoskeletal pain, renal colic, gout, and trauma-related pain.

Administration: Given via intramuscular (IM) or intravenous (IV) injection; the typical dose is 75 mg once or twice daily, depending on the severity of pain.

Precautions & Side Effects: May cause gastrointestinal irritation, nausea, headache, dizziness, and rarely serious effects like gastrointestinal bleeding or renal impairment. Not recommended in patients with NSAID hypersensitivity or active bleeding.

Key Features

Potent Analgesic & Anti‑Inflammatory: Each 3 mL vial contains 75 mg Diclofenac Sodium, ensuring effective management of acute pain and inflammation.

Rapid Onset of Action: Water‑based formulation facilitates swift systemic absorption, delivering relief within 10–15 minutes post‑administration.

Sterile, Pyrogen‑Free: Manufactured under GMP‑certified facilities; undergoes multilayered sterility testing to eliminate microbial contaminants and pyrogens.

IP‑Compliant Quality: Conforms to the stringent criteria outlined in the Indian Pharmacopoeia for identity, potency, and purity.

Low Endotoxin Levels: Stringent in‑process control ensures endotoxin content remains well below pharmacopeial limits, maximizing patient safety.

Clinical Benefits

Efficient Pain Management: Ideal for postoperative pain, musculoskeletal injuries, and acute flare‑ups of rheumatoid arthritis.

Reduced Hospital Stay: Accelerated pain control can contribute to earlier mobilization and shortened inpatient duration.

Versatile Administration: Suitable for intramuscular or slow intravenous injection, offering flexibility across diverse care settings.

Minimized Adverse Events: Controlled osmolarity and buffering reduce local tissue irritation, enhancing patient comfort.

Cost‑Effective Therapy: High potency per vial reduces dosing frequency, making Fenac AQ an economical choice for bulk procurement.

Contact us today to request a sample, access our detailed product dossier, or discuss customized pricing and delivery schedules.

• Tepsin is a high-quality Terlipressin Injection 0.1mg/ml, indicated for the emergency treatment of bleeding esophageal varices and acute complications of portal hypertension in patients with liver cirrhosis. Manufactured under stringent quality standards, Tepsin ensures efficacy, safety, and consistent therapeutic outcomes.

   

  This injection is widely prescribed in critical care units, gastroenterology wards, and emergency settings due to its reliable vasoconstrictive properties that help reduce portal vein pressure.

Key Features & Benefits

• Optimized Concentration: Each milliliter contains 0.1 mg of Terlipressin, ensuring accurate titration and minimal dosage variability.

• WHO‑GMP Compliance: Produced in state‑of‑the‑art facilities, guaranteeing sterility, potency, and batch‑to‑batch consistency.

• Sterile Solution: Supplied as a preservative‑free, ready‑to‑use injection to streamline point‑of‑care administration.

• Enhanced Stability: Advanced formulation confers extended shelf life at controlled temperatures, reducing product wastage.

• Lifesaving Vasoconstrictor: Clinically proven to elevate mean arterial pressure in hepatorenal syndrome and variceal bleeding.

• Management of hepatorenal syndrome in patients with cirrhosis

• Hemodynamic stabilization during variceal hemorrhage

• Adjunct therapy in septic shock where fluid resuscitation alone is insufficient

Why Partner with Us

• Dedicated Supply Chain: Robust logistics network ensures on‑time delivery, even in remote geographies.

• Regulatory Expertise: Comprehensive documentation support for drug master files, import clearances, and local registrations.

• Customized Packaging: Options for bulk vials, pre‑filled syringes, and hospital‑ready trays to suit diverse procurement models.

• Technical Support: Access to our medical affairs team for pharmacovigilance, dosing protocols, and on‑site training.

• Fecimalt L is a high-quality intravenous iron formulation containing Ferric Carboxymaltose 500mg/10ml, specially indicated for the treatment of iron deficiency anemia (IDA) in adult patients where oral iron preparations are ineffective or not well tolerated.

   

  This ready-to-use IV iron therapy offers rapid iron replenishment, ensures better hemoglobin recovery, and improves overall patient compliance. Fecimalt L is manufactured under stringent quality standards ensuring purity, stability, and safety.

Key Features & Specifications

• High‐Strength Formulation: 500 mg elemental iron per 10 mL vial for efficient replenishment.

• Stable Complex Technology: Ferric carboxymaltose matrix ensures controlled iron release, reducing free‐iron toxicity.

• Rapid Infusion Protocol: Administer up to 1,000 mg in one session (over 15–30 minutes), optimizing clinic throughput.

• Sterile, Pyrogen‐Free: Manufactured under GMP guidelines; each vial undergoes stringent sterility and endotoxin testing.

Clinical Benefits

• Accelerated Hemoglobin Recovery: Clinical studies demonstrate significant hemoglobin rise within one week of administration.

• Enhanced Patient Tolerance: Low incidence of infusion‐related adverse events due to non‐dextran, non‐complexed iron formulation.

• Streamlined Treatment Workflow: Reduced number of hospital visits with high‐dose, single‐session dosing.

• Introducing Fibroclot 25, a high-quality Heparin Sodium Injection IP formulated to deliver 25000 IU per 5ml, specifically manufactured to meet stringent healthcare standards. It is used for the prevention and treatment of blood clots, ensuring enhanced patient outcomes in critical care settings.

   

  This anticoagulant injection is ideal for hospitals, clinics, and pharmaceutical distributors seeking reliable, GMP-certified injectable solutions at competitive pricing.

• High‑Potency Formulation: 25,000 IU per 5 mL delivers precise anticoagulant activity.

• Regulatory Compliance: Manufactured in a WHO‑GMP‑certified facility, fully compliant with IP (Indian Pharmacopoeia) standards.

• Sterility Assurance: 100% batch‑released after bacterial endotoxin and sterility testing.

• Quality Control: Stringent in‑process checks, validated manufacturing lines, and real‑time stability monitoring.

• Optimized Packaging: Tamper‑evident glass vials with overwrap to maintain cold‑chain integrity.

• Effective Thromboprophylaxis: Prevents venous thromboembolism (VTE) in high‑risk surgical and medical patients.

• Rapid Onset of Action: Immediate anticoagulation allows for better perioperative management.

• Reduced Risk Profile: Low molecular interference promotes predictable pharmacokinetics.

• Seamless Integration: Compatible with standard infusion pumps and syringes.

• Primary Packaging: 5 mL sterile glass vials, 10 vials per carton.

• Secondary Packaging: Corrugated export‑grade cartons with thermal insulation.

• Supply Chain: ISO 9001:2015‑accredited logistics ensures on‑time, temperature‑controlled delivery.

• End‑to‑End Compliance: From raw‑material traceability to final QC release, we maintain GMP adherence at every step.

• Scalable Capacity: Annual production capacity exceeding 5 million doses.

• Technical Support: Dedicated medical affairs team for product inquiries, regulatory dossiers, and stability data.

• Competitive Pricing: Economies of scale allow us to optimize cost without compromising on quality.

• Penrisun 40 (Pantoprazole Injection 40mg) is a highly effective proton pump inhibitor used for the short-term treatment of acid-related disorders. Ideal for hospitals and critical care setups, this injectable form offers rapid relief from gastroesophageal reflux disease (GERD), erosive esophagitis, and Zollinger-Ellison syndrome. Manufactured under WHO-GMP-certified facilities, Penrisun 40 ensures purity, potency, and safety. It is widely trusted by healthcare professionals for IV use when oral therapy is not feasible

• High‑Potency Acid Suppression

  • Delivers 40 mg of Pantoprazole per vial for consistent, predictable inhibition of gastric H⁺/K⁺ ATPase pumps.

  • Rapid onset of action supports emergency and inpatient protocols (e.g., IV bolus or infusion).

• Pharmaceutical‑Grade Formulation

  • Sterile, non‑pyrogenic solution in pH‑optimized buffer for enhanced stability.

  • Complies with IP/BP/USP monographs, backed by comprehensive batch‑release testing.

• Optimized for Ease of Use

  • Ready‑to‑dilute vial format minimizes preparation time in high‑throughput settings.

  • Transparent labeling and tamper‑evident seals ensure patient safety.

• Robust Supply Chain & Compliance

  • Manufactured in WHO‑GMP–certified facility with ISO 9001:2015 quality management.

  • Full traceability from raw material sourcing through final distribution

• Erosive reflux esophagitis

• Zollinger–Ellison syndrome and other hypersecretory conditions

• Prophylaxis of stress‑related mucosal damage in critically ill patients

• Riyanim (Nimodipine Injection BP) is a calcium channel blocker used for the prevention and treatment of neurological complications resulting from subarachnoid hemorrhage (SAH). It is specially formulated to support cerebral blood flow by relaxing blood vessels in the brain, thereby reducing the risk of further brain damage after bleeding.

   

  This injection is widely used in ICU settings and is known for its consistent therapeutic outcomes. Riyanim offers superior quality, cost-effective pricing, and high demand across hospitals, pharmacies, and distributors in India.

• High-Purity Nimodipine BP (1 mg/ml): Manufactured under WHO‑GMP guidelines, guaranteeing compliance with global quality benchmarks.

• Optimized Solvent System: Minimizes precipitation risk, ensuring smooth intravenous infusion.

• Rapid Cerebral Penetration: Designed for effective management of subarachnoid hemorrhage–induced vasospasm.

• Scalable Supply Chain: Consistent monthly capacity of 100,000 vials supports large‑scale hospital procurement.

• Low-Competition Keywords: Strategically optimized for “nimodipine injection BP infusion supplier in India,” “nimodipine intravenous therapy,” and “cerebral vasospasm medication.”

• Cerebral Vasospasm Prevention: Post-subarachnoid hemorrhage care to reduce morbidity.

• Neurocritical Infusion Therapy: Adjunct in acute ischemic stroke management.

• NICU & ICU Formulations: Ideal for continuous infusion protocols in neuro ICU settings.

• Strategic Advantage: Leverage our dedicated R&D pipeline to access next‑generation neurovascular therapies.

• Customized Solutions: Flexible contract manufacturing and private‑label options to strengthen your portfolio.

• Dedicated Support: 24×7 technical helpline, regulatory dossiers, and onboarding assistance to streamline market entry.